Physician profile
Mark E Maxwell
NPI 1699723692
$8,408.29
in general payments reported to CMS, 2019-2025
42 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $1,247 · 2021: $1,673 · 2022: $1,385 · 2023: $1,430 · 2024: $1,011 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,530.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,313.50 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $1,093.76 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $972.28 | 2019-2025 | Evenity, Repatha, Otezla |
| Abbvie INC. | $773.90 | 2020-2025 | |
| Pfizer INC. | $638.11 | 2019-2025 | |
| Lilly USA, LLC | $440.79 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $365.30 | 2019-2025 | Jardiance |
| Medicure Pharma INC. | $296.13 | 2020-2023 | Zypitamag |
| Kowa Pharmaceuticals America, INC. | $289.28 | 2019-2025 | Zoryve, Seglentis |
| Exact Sciences Corporation | $256.12 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $252.66 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $201.10 | 2020-2021 | |
| Novo Nordisk INC | $175.43 | 2019-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $138.58 | 2020-2025 | Capvaxive, Gardasil 9, Gardasil |
| Biohaven Pharmaceutical Holding Company Ltd. | $130.21 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.